Baolingbao Biology Co.,Ltd.

SZSE:002286 Voorraadrapport

Marktkapitalisatie: CN¥2.5b

Baolingbao BiologyLtd Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Baolingbao BiologyLtd has been growing earnings at an average annual rate of 11%, while the Food industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 6.6% per year. Baolingbao BiologyLtd's return on equity is 5.4%, and it has net margins of 4.6%.

Belangrijke informatie

11.0%

Groei van de winst

11.1%

Groei van de winst per aandeel

Food Groei van de industrie7.2%
Inkomstengroei6.6%
Rendement op eigen vermogen5.4%
Nettomarge4.6%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

Recent updates

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

Oct 08
Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

Sep 30
We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Jul 03
Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

Jun 07
Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

Opbrengsten en kosten

Hoe Baolingbao BiologyLtd geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SZSE:002286 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 242,3921097511
30 Jun 242,428919211
31 Mar 242,465609811
31 Dec 232,5245411111
30 Sep 232,597691468
30 Jun 232,612751409
31 Mar 232,6651071348
01 Jan 232,7131331278
30 Sep 222,7691521348
30 Jun 222,88622812212
31 Mar 222,86823512813
01 Jan 222,76520212613
30 Sep 212,58915712117
30 Jun 212,3007110812
31 Mar 212,2094511211
31 Dec 202,0555010611
30 Sep 202,0374912211
30 Jun 201,9555415411
31 Mar 201,8103916010
31 Dec 191,805351829
30 Sep 191,785391884
30 Jun 191,778301875
31 Mar 191,740391815
31 Dec 181,730431725
30 Sep 181,649511614
30 Jun 181,615501516
31 Mar 181,605501506
31 Dec 171,593501495
30 Sep 171,583521434
30 Jun 171,553551590
31 Mar 171,477501540
31 Dec 161,377491560
30 Sep 161,271451510
30 Jun 161,200421370
31 Mar 161,175391370
31 Dec 151,196411270
30 Sep 151,155281230
30 Jun 151,078261130
31 Mar 15992241040
31 Dec 1491123990
30 Sep 1494134950
30 Jun 1496341990
31 Mar 1490141940
31 Dec 1390141970

Kwaliteitswinsten: 002286 has a large one-off gain of CN¥28.5M impacting its last 12 months of financial results to 30th September, 2024.

Groeiende winstmarge: 002286's current net profit margins (4.6%) are higher than last year (2.6%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 002286's earnings have grown by 11% per year over the past 5 years.

Versnelling van de groei: 002286's earnings growth over the past year (59%) exceeds its 5-year average (11% per year).

Winst versus industrie: 002286 earnings growth over the past year (59%) exceeded the Food industry -6%.


Rendement op eigen vermogen

Hoge ROE: 002286's Return on Equity (5.4%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden